Wajeeh Khan’s Post

𝐎𝐮𝐫 𝐁𝐂𝐅 𝐟𝐮𝐧𝐝 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝 𝐢𝐦𝐩𝐫𝐞𝐬𝐬𝐢𝐯𝐞 𝐫𝐞𝐭𝐮𝐫𝐧𝐬 𝐢𝐧 𝐣𝐮𝐬𝐭 10 𝐦𝐨𝐧𝐭𝐡𝐬! We’re thrilled to share that we launched the 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐂𝐲𝐜𝐥𝐞 𝐅𝐮𝐧𝐝 (𝐁𝐂𝐅) in November 2023, and it has proven to be very beneficial for our investors. Our goal in launching BCF was to allow people to invest in sectors that were ready to bounce back, particularly in areas where market disbelief had lowered prices. Since its inception on November 11, 2023, through September 30, 2024, 𝐨𝐮𝐫 𝐜𝐥𝐢𝐞𝐧𝐭'𝐬 𝐩𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨𝐬 𝐡𝐚𝐯𝐞 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐚 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 36.34%. Finally, we transformed doubt into hope for our investors! BCF was designed to provide flexibility in pursuing the best opportunities and possibilities, with a key focus on the pharmaceutical sector. Now, investors are also excited about our upcoming investment strategies! Are you one of them? Comment below. #Profits #Investmentprofit #Fundsmanager #Wealthmanagement #PortfolioManagement

Discover the latest trends in early-stage biopharma investments with our comprehensive report, "Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective." From Series A financing peaks to the dominance of biologicals and the resurgence of biopharma IPOs, get all the insights you need to stay ahead in the market. 📥 Download your free copy today! 👉 https://ter.li/wtpcs3 #Biopharma #InvestmentTrends #SeriesAFinancing #BeaconData #MarketInsights #InvestmentStrategy

As a member of the Student Managed Investment Fund (SMIF) Club, I recently completed an extensive equity analysis presentation on Auropharma, Pharmaceutical Company, a journey that deepened my understanding across macroeconomic, industry, trend, financial, and company analysis. This comprehensive course equipped me with the critical skills to make informed decisions on whether to buy, hold, or sell shares of the company. Grateful for the opportunity to translate theory into practice. #EquityResearch #InvestmentAnalysis #FinancialMarkets

👨🏫 This week in global financial media site Seeking Alpha : Read my research paper on the parent company of #Croatia's #pharma giant PLIVA, Israel-based Teva Pharmaceuticals, a leading #genericdrugs maker globally & with a pipeline of drug #innovations in the #oncology space & other segments, its #stock trading on the #NYSE as #investors look for growth indicators. 📉 📊 https://lnkd.in/gNQaDv9g

Thoughts on this? >> Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #healthcare #biotech

This is a ratio of Nifty Pharma vs Nifty, we invested in the Pharma index fund, in June 2023, and it has given fabulous returns in the past 1 year, much better than the Nifty index fund. I even moved my portfolio to pharma midcap companies, to get better returns. It might give a much better return than the Nifty Index fund in future. Disc- Not a buy or sell recommendation. Past returns are not a guarantee of future returns, and this is especially true for funds. #etf #indexfund #fund #pharma #nifty

The median M&A upfront cash and equity for biopharma transactions on the buy-side has shown significant variation from 2018 to 2024. The most notable spike occurred in the second half of 2021, reaching $412 million. This was followed by a notable increase in the first half of 2024 at $300 million. Other periods displayed lower median values, such as $67 million in the first half of 2020 and $85 million in the second half of 2018. Overall, the trend highlights fluctuating but substantial investment levels in biopharma M&A deals over recent years. Want to see more charts like this? Schedule your demo https://hubs.ly/Q02JjyKF0

Only put off until tomorrow what you are willing to die having left undone. Regeneron Pharmaceuticals Stock Outperforms S&P 500: A Great Opportunity for HSA Investors! 🚀📈💰 Regeneron Pharmaceuticals has proven its mettle by outperforming the broader S&P 500 Index in the past year. This fantastic achievement makes it an exciting prospect for investors looking to grow their Health Savings Accounts (HSAs). Wall Street analysts, renowned for their expertise, remain highly optimistic about the stock's future performance. 🔬🔝📊 Regeneron Pharmaceuticals is a key player in the healthcare industry, and its exceptional track record positions it as an attractive investment option within the sector. With the persistent advancements in medical research and breakthrough treatments, Regeneron Pharmaceuticals stands at the forefront of innovation, ensuring a bright future for the company. ⏳🛡️⚡ To avoid the Fear of Missing Out (FOMO), take action now and consider including Regeneron Pharmaceuticals in your HSA investment portfolio. By seizing this opportunity, you can align your financial goals with your commitment to health and wellness. 🤝🌟📈 Investing in Regeneron Pharmaceuticals not only supports advancements in healthcare but also allows you to harness the potential for significant financial growth. Join the movement of savvy investors who are capitalizing on the promising prospects of healthcare stocks. #hsa #investing #healthcare #health #family #wellness 🚀📈💰

Procrastination is the art of keeping up with yesterday. Don't miss out on the potential growth of Gilead Sciences! 🌟📈 Gilead Sciences, a leading biopharmaceutical company, has recently faced challenges that resulted in its underperformance compared to the broader Nasdaq Composite. However, analysts remain reasonably bullish about the stock's future outlook. 📊🔬 Investing in healthcare can provide exciting opportunities for long-term growth and add value to your Health Savings Account (HSA). By allocating a portion of your HSA funds to Gilead Sciences, you can potentially benefit from their innovative medical advancements and contribute to the overall health and wellness of your family. 💪💰👨👩👧👦 With the healthcare industry constantly evolving, it is essential to act now to avoid the Fear of Missing Out (FOMO) on potential gains. By seizing this opportunity, you can align your financial goals with your passion for investing in the healthcare sector. 💼🚀 Invest in Gilead Sciences today and take advantage of the potential growth opportunities they offer. 📈💡 Maximize the potential of your HSA and invest in a company dedicated to improving global health outcomes. 🌍💊 #hsa #investing #healthcare #health #family #wellness 💰🏥💪👨👩👧👦

Thoughts on this? >> Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #competitivemarketing #biotech